1-4 of 4
Inge Marie Svane
Close
Sort by
Journal Articles

Therapeutic Cancer Vaccination Targeting Shared Tumor Associated Antigens in Combination with Azacitidine for High Risk Myelodysplastic Syndrome - a Phase I Clinical Trial

Staffan Holmberg-Thydén, MD, Inge Høgh Dufva, MDPhD, Anne Ortved Gang, MDPhD, Marie Fredslund Breinholt, MD, Lone Schejbel, PhD, Mette Klarskov Andersen, MD DMSc, Mohammad Kadivar, PhD, Inge Marie Svane, Prof,MDPhD, Kirsten Grønbæk, Prof,MDDMSc, Sine Reker Hadrup, Prof, Daniel El Fassi, MDPhD
Journal: Blood
Blood (2020) 136 (Supplement 1): 23–24.
https://doi.org/10.1182/blood-2020-142806
Published: 2020
Journal Articles

Increase in circulating CD4 + CD25 + Foxp3 + T cells in patients with Philadelphia-negative chronic myeloproliferative neoplasms during treatment with IFN-α

Brief Report
Caroline Hasselbalch Riley, Morten Krogh Jensen, Marie Klinge Brimnes, Hans Carl Hasselbalch, Ole Weis Bjerrum, Per thor Straten, Inge Marie Svane
Journal: Blood
Blood (2011) 118 (8): 2170–2173.
https://doi.org/10.1182/blood-2011-03-340992
Published: 2011
Journal Articles

Indoleamine 2,3-dioxygenase specific, cytotoxic T cells as immune regulators

Rikke Bæk Sørensen, Sine Reker Hadrup, Inge Marie Svane, Mads Christian Hjortsø, Per thor Straten, Mads Hald Andersen
Journal: Blood
Blood (2011) 117 (7): 2200–2210.
https://doi.org/10.1182/blood-2010-06-288498
Published: 2011
Journal Articles

Immunogenicity of Bcl-2 in patients with cancer

Mads Hald Andersen, Inge Marie Svane, Pia Kvistborg, Ove Juul Nielsen, Eva Balslev, Sine Reker, Jürgen C. Becker, Per thor Straten
Journal: Blood
Blood (2005) 105 (2): 728–734.
https://doi.org/10.1182/blood-2004-07-2548
Published: 2005